Healthy volunteers needed to test safety of experimental drug TLC-1180
NCT ID NCT07300189
First seen Jan 06, 2026 · Last updated May 22, 2026 · Updated 28 times
Summary
This early-stage study tests the safety of a new drug, TLC-1180, in healthy adults aged 18 to 55. Researchers will give single or multiple doses to see how the body handles the drug and if it causes side effects. About 288 participants will take part. This study does not aim to treat any disease; it collects important safety information for future research.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
OrsoBio Research Site
RECRUITINGAuckland, New Zealand
Conditions
Explore the condition pages connected to this study.